- Reuters•4 hours ago
The following are the top stories on the business pages of British newspapers. Ofgem has issued a warning shot to the Big Six suppliers against raising prices, saying there was no "obvious reason" for them to increase standard tariffs. Rolls-Royce Holdings Plc, which this week agreed to pay 671 million pounds in penalties after admitting it had engaged in corruption, lobbied ministers to weaken proposed curbs on bribery a decade ago.
- Investopedia•11 hours ago
GlaxoSmithKline announced a key change in its management structure. But there are other issues at play in the slow-growth pharma industry.
- Reuters•19 hours ago
LONDON/DAVOS, Switzerland, Jan 19 (Reuters) - G laxoSmithKline's global head of pharmaceuticals, Abbas Hussain, is to leave Britain's biggest drugmaker after being passed over for the top job and will be replaced by Luke Miels from AstraZeneca. Hussain, the brother of former England cricket captain Nasser Hussain, had been a contender to take over from Chief Executive Andrew Witty, who steps down at the end of March, but the job went to GSK's consumer health boss Emma Walmsley.
GSK : Summary for GlaxoSmithKline PLC Common Stoc - Yahoo Finance
GlaxoSmithKline plc (GSK)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||38.67 - 39.08|
|52 Week Range||37.20 - 45.58|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||251.62|
|Dividend & Yield||1.85 (4.70%)|
|1y Target Est||N/A|